SkyePharma PLC welcomes announcement by its partner GlaxoSmithKline that the US Food & Drug Administration (FDA) has approved an additional therapeutic application for Paxil CR (paroxetine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback